BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30588277)

  • 1. The Effect of Telerehabilitation on Missed Appointment Rates.
    Covert LT; Slevin JT; Hatterman J
    Int J Telerehabil; 2018; 10(2):65-72. PubMed ID: 30588277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telerehabilitation for Lee Silverman Voice Treatment (Tele-LSVT)-Loud on voice intensity and voice use in daily living in people with multiple sclerosis: A protocol for a feasibility and pilot randomized controlled study.
    Vitali C; Fusari G; Baldanzi C; Cacciatore DM; Crispiatico V; Carullo A; Rovaris M; Cattaneo D; Baglio F; Isernia S
    Digit Health; 2023; 9():20552076231218150. PubMed ID: 38074343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.
    Baldanzi C; Crispiatico V; Foresti S; Groppo E; Rovaris M; Cattaneo D; Vitali C
    J Voice; 2022 Jul; 36(4):585.e1-585.e13. PubMed ID: 32819780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
    Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
    Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Interval From Initial Evaluation to Initial Voice Therapy Session is Associated With Missed Voice Therapy Appointments.
    Gustin RL; Pielage KC; Howell R; Khosla S; Giliberto JP
    J Voice; 2020 Nov; 34(6):870-873. PubMed ID: 31176529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of home telerehabilitation for speech treatment in people with Parkinson's disease.
    Saiyed M; Hill AJ; Russell TG; Theodoros DG; Scuffham P
    J Telemed Telecare; 2022 Aug; 28(7):524-529. PubMed ID: 32847466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
    Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
    Trials; 2020 May; 21(1):436. PubMed ID: 32460885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition to telemedicine and its impact on missed appointments in community-based clinics.
    Adepoju OE; Chae M; Liaw W; Angelocci T; Millard P; Matuk-Villazon O
    Ann Med; 2022 Dec; 54(1):98-107. PubMed ID: 34969330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voice telerehabilitation in Parkinson's disease.
    Dias AE; Limongi JC; Barbosa ER; Hsing WT
    Codas; 2016 Apr; 28(2):176-81. PubMed ID: 27191882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson's disease: A pilot study.
    Quinn R; Park S; Theodoros D; Hill AJ
    Int J Speech Lang Pathol; 2019 Aug; 21(4):385-394. PubMed ID: 29879854
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.
    Liu Q; Abba K; Alejandria MM; Sinclair D; Balanag VM; Lansang MA
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006594. PubMed ID: 25403701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device: A non-inferiority study.
    Griffin M; Bentley J; Shanks J; Wood C
    J Telemed Telecare; 2018 Apr; 24(3):209-215. PubMed ID: 28147896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
    Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Quality of Life Outcomes of Speech Treatment for Parkinson's Disease Delivered to the Home Via Telerehabilitation: A Noninferiority Randomized Controlled Trial.
    Theodoros DG; Hill AJ; Russell TG
    Am J Speech Lang Pathol; 2016 May; 25(2):214-32. PubMed ID: 27145396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why military personnel fail to keep medical appointments.
    Thornton R; Ballard K
    J R Army Med Corps; 2008 Mar; 154(1):26-30. PubMed ID: 19090383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease.
    Nakayama K; Yamamoto T; Oda C; Sato M; Murakami T; Horiguchi S
    Rehabil Res Pract; 2020; 2020():6585264. PubMed ID: 32411475
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.